ACL-R Opioid Sparing Study
Part of paid clinical trials in Memphis, Tennessee.
- Sponsor
- Campbell Clinic
- Study ID
- NCT06561035
- Phase
- PHASE3
- Status
- Enrolling By Invitation
Conditions
- Anterior Cruciate Ligament Injuries
Eligibility Criteria
- Sex
- ALL
- Age
- 14 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Opiate Sparing — DRUGSubjects will receive medications in the Opiate Sparing arm for pain control.
- Opiate Based — DRUGSubjects will receive medications in the Opiate Based arm for pain control.
Study Details
This is a randomized control trial to investigate the effectiveness of a multimodal opiate sparing analgesic regimen in controlling post-operative pain and potentially reduce post-operative opioid consumption in patients undergoing Anterior Cruciate Ligament Reconstruction (ACL-R).
Key Dates
- Start date
- Sep 1, 2024
- Status verified
- Aug 2024
- Primary completion
- Aug 31, 2025
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 56 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Opiate SparingDischarge medications: 1. Medrol Dosepak, take per package instructions from postoperative day 1 to postoperative day 6. 2. Diclofenac 75 milligram (mg) twice per day from postoperative day 7 to postoperative day 14. 3. Tylenol 1000 mg three times per day from postoperative day 1 to postoperative day 14. 4. Gabapentin 100 mg three times per day from postoperative day 1 to postoperative day 14. 5. Methocarbamol (Robaxin) 750mg twice per day from postoperative day 1 to postoperative day 14. 6. Promethazine 25 mg every 8 hours as needed for nausea. 7. Aspirin 81 once per day from postoperative day 1 to postoperative day 30. 8. Senokot-S (Sennosides and Docusate) as needed for constipation. 9. 10 tablets of Tramadol 50mg as needed for moderate breakthrough pain only. 10. 5 tablets of oxycodone 5mg as needed for severe breakthrough pain only. 11. Supervised physical therapy to start within postoperative day 2 and postoperative day 7.
- Active Comparator: Opiate BasedDischarge medications: 1. Diclofenac 75 milligram (mg) twice per day from postoperative day 1 to postoperative day 14. 2. Tylenol 1000 mg three times per day from postoperative day 1 to postoperative day 14. 3. Gabapentin 100 mg three times per day from postoperative day 1 to postoperative day 14. 4. Methocarbamol (Robaxin) 750mg twice per day from postoperative day 1 to postoperative day 14. 5. Promethazine 25 mg every 8 hours as needed for nausea. 6. Aspirin 81 once per day from postoperative day 1 to postoperative day 30. 7. Senokot-S (Sennosides and Docusate) as needed for constipation. 8. 10 tablets of Tramadol 50mg as needed for moderate breakthrough pain only. 9. 5 tablets of oxycodone 5mg as needed for severe breakthrough pain only. 10. Supervised physical therapy to start within postoperative day 2 and postoperative day 7.
Primary Outcome Measure
Visual Analog Scale [ Time Frame: Once per day from postoperative day 1 to postoperative day 14; at two weeks follow up visit, 6 weeks follow up visit and 12 weeks follow up visit. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Campbell Clinic | Memphis | Tennessee | 38138 | - |
Find similar trials in Memphis, TN
By research site
Related Studies
- Biologic Therapy to Prevent Osteoarthritis After ACL InjuryEARLY_PHASE1 · Recruiting · University of California, Los Angeles · Los Angeles, California
- Vibration and Post-traumatic Osteoarthritis Risk Following ACL InjuryRecruiting · University of North Carolina, Chapel Hill · Chapel Hill, North Carolina
- PRP in ACLR to Prevent PTOAPHASE3 · Recruiting · Hospital for Special Surgery, New York · New York, New York
- Quadriceps Tendon Versus Bone Patellar Tendon Bone Autograft ACL Reconstruction RCTRecruiting · University of Alabama at Birmingham · Birmingham, Alabama